Molecular Quality Controls Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3537
Molecular Quality Controls Market size is expected to grow significantly from 2019 to 2025.
Increasing need for accurate and sensitive diagnosis will augment demand for molecular quality control products that will exceed business growth in analysis time frame. Every year, millions of people are diagnosed with infectious diseases across the globe. Obtained diagnosis result are crucial for patient’s further treatment procedure. If implication of achieved report is testified as either false positive or negative, then it will result in devasting repercussions. As a result, for obtaining accurate and efficient result, demand for molecular quality control products will surge that will augment industry growth.
Growing focus of industry players on manufacturing molecular diagnostic tests for detecting cancer and identifying infectious diseases will prove beneficial for business growth. Companies are focusing on R&D activities and developing technologically advanced control products that provide unbiased and independent testing proficiency. These products are used to monitor extraction and amplification steps to evaluate consistency of test kits and assay reagents. As a result, efforts undertaken by companies to provide innovative solutions will accelerate its demand thereby, fueling market growth. However, high cost associated with molecular control products mat hinder business growth up to certain extent.
Independent product type segment is anticipated to witness substantial growth in analysis time frame. Significant growth is attributed to benefits offered by these products such as potential to detect performance shifts that will increase patient’s confidence. Additionally, independent molecular quality control is produced under stringent quality standard protocols that offers reliability. Furthermore, they provide accurate results for longer span without need for constant evaluations despite of fluctuations. Aforementioned advantages offered by independent control product will increase its adoption that will augment business revenue.
Multi-analyte segment has lucrative revenue share in 2018 and it is estimated to surge enormously in forecast timeline. Substantial revenue share is attributed to wide range of application provided by multi-analyte control products. Multi-analyte monitors performance of numerous tests such as in vitro laboratory nucleic acid testing protocol, HIV, hepatitis, nucleic acid, etc. It aids in reducing risk associated with reporting inaccurate results. Additionally, early detection combined with appropriate infection control procedure should prevent spread of diseases resulting in enhanced patient care. Thus, benefits offered by multi-analyte will increase its demand that will exceed its segment growth.
Oncology segment is expected to witness robust growth over the analysis time period. Significant growth is attributed to increasing prevalence of cancer and rising focus of research institutes to develop medicines to cure patients. Scientists and researchers are emphasizing on drug discovery that highly requires quality control units to validate effectiveness of the medicines. Moreover, rising focus on manufacturing alternative and personalized medicines will augment demand for molecular quality control products to maintain accuracy in the process. As a result, rising prevalence of cancer coupled with increasing scientists focus on drug discovery will drive segment growth.
Clinical and research laboratories had lucrative revenue in 2018 and it will augment in coming years. Increasing prevalence of chronic disease combined with benefits of early diagnosis with appropriate control measures will rise demand for products in clinical and research laboratories. Increasing patient pool for accurate diagnosis and rising extensive research on developing medicines will upsurge demand for molecular quality control products that will fuel segment growth.
North America molecular quality control market is anticipated to witness significant CAGR in analysis timeframe owning to high adoption of technologically advanced products. Strong foothold of industry players and huge number of established research institutes will contribute for regional market growth. Additionally, increasing prevalence of infectious disease in the region will increased demand for molecular diagnostic tests. As per CDC, in 2016, 15.5 million patient visited physician for diagnosing infectious and parasitic diseases. Thus, presence of abundant patient pool for accurate diagnosis will fuel regional market growth.
Some of the major industry players operating in the molecular quality controls market include Bio-Rad Laboratories Inc., SeraCare Life Sciences Inc., ZeptoMetrix Corporation, Microbiologics Inc, Abbott Laboratories, Thermo Fisher Scientific, Roche Diagnostics, Quidel Corporation, Qnostics Ltd. and Maine Molecular Quality Controls Inc. For instance, in January 2017, Bio-Rad launched Amplichek STI that is a multi-analyte control product monitoring performance of various tests. This strategy aimed to expand product portfolio that will help company to sustain in the market.
Molecular Quality Controls Market by Product type, 2014-2025 (USD Million)
- Instrument Specific
Molecular Quality Controls Market by Analyte type, 2014-2025 (USD Million)
- Single analyte
Molecular Quality Controls Market by Application, 2014-2025 (USD Million)
- Infectious disease
- Blood screening
- Genetic Testing
- Other Applications
Molecular Quality Controls Market by End-use, 2014-2025 (USD Million)
- Clinical and research laboratories
- Blood centers
- IVD manufacturers
- Academic & Research Institutes
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Bio-Rad Laboratories Inc.
- SeraCare Life Sciences Inc.
- ZeptoMetrix Corporation
- Microbiologics Inc
- Abbott Laboratories
- Thermo Fisher Scientific
- Roche Diagnostics
- Quidel Corporation
- Maine Molecular Quality Controls Inc
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.